7R4I

The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody

Summary for 7R4I

• Entry DOI: 10.2210/pdb7r4i/pdb
• EMDB information: 14313
• Descriptor: Spike glycoprotein, Camel-derived nanobody 2.15, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
• Functional Keywords: coronavirus, covid-19, sars-cov-2, spike, nanobodies, neutralization, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2; More
• Total number of polymer chains: 5
• Total formula weight: 457702.55

Authors

Casasnovas, J.M.,Melero, R.,Arranz, R.,Fernandez, L.A. (deposition date: 2022-02-08, release date: 2022-06-08)

• Primary citation: Casasnovas, J.M.,Margolles, Y.,Noriega, M.A.,Guzman, M.,Arranz, R.,Melero, R.,Casanova, M.,Corbera, J.A.,Jimenez-de-Oya, N.,Gastaminza, P.,Garaigorta, U.,Saiz, J.C.,Martin-Acebes, M.A.,Fernandez, L.A.; Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron.; Front Immunol, 13:863831-863831, 2022; PubMed: 35547740; DOI: 10.3389/fimmu.2022.863831

Experimental method

ELECTRON MICROSCOPY (3.2 Å)